ASEM documentary overview
Official National Advisory Committee on Immunization document (2022) on “Recombinant influenza vaccines: A supplemental statement of the Canadian Immunization Guide chapter on influenza and statement on seasonal influenza vaccine for 2022–2023”. The objective of this statement is to review the available evidence on the efficacy, effectiveness, immunogenicity, and safety of Supemtek, and to provide guidance on its use among adults in Canada.
This overview helps you identify the document. Always consult the current official publication for clinical recommendations.
Official document